Clinical Impact of COVID-19 on Multi-Drug-Resistant Gram-Negative Bacilli Bloodstream Infections in an Intensive Care Unit Setting: Two Pandemics Compared

Clinical Impact of COVID-19 on Multi-Drug-Resistant Gram-Negative Bacilli Bloodstream Infections in an Intensive Care Unit Setting: Two Pandemics Compared

Two mutually related pandemics are ongoing worldwide: the COVID-19 and antimicrobial resistance pandemics. This study aims to evaluate the impact of COVID-19 on multi-drug-resistant Gram-negative bacteria (MDR-GN) bloodstream infections (BSIs) in a single intensive care unit (ICU). We conducted a re...

Full description

Bibliographic Details
Main Authors:	Francesco Cogliati Dezza, Gabriele Arcari, Federica Alessi, Serena Valeri, Ambrogio Curtolo, Federica Sacco, Giancarlo Ceccarelli, Giammarco Raponi, Francesco Alessandri, Claudio Maria Mastroianni, Mario Venditti, Alessandra Oliva
Format:	Article
Language:	English
Published:	MDPI AG 2022-07-01
Series:	Antibiotics
Subjects:	antibiotic therapy multi-drug-resistant bacteria COVID-19 bloodstream infections intensive care unit
Online Access:	https://www.mdpi.com/2079-6382/11/7/926

Similar Items

Are Follow-Up Blood Cultures Useful in the Antimicrobial Management of Gram Negative Bacteremia? A Reappraisal of Their Role Based on Current Knowledge
by: Francesco Cogliati Dezza, et al.
Published: (2020-12-01)

Risk factors for nosocomial bloodstream infection caused by multidrug resistant gram-negative bacilli in pediatrics
by: Mariana V. Arnoni, et al.

Specific dynamic of serum procalcitonin in critically ill patients affected by Gram-negative bacilli septic thrombophlebitis
by: Martina Spaziante, et al.
Published: (2018-07-01)

NEW INSIGHT ON EPIDEMIOLOGY AND MANAGEMENT OF BACTERIAL BLOODSTREAM INFECTION IN PATIENTS WITH HEMATOLOGICAL MALIGNACIES
by: Sara Lo Menzo, et al.
Published: (2015-07-01)

Bloodstream Infection and Gram-Negative Resistance: The Role for Newer Antibiotics
by: Jessica Waters, et al.
Published: (2023-05-01)

DALBACEN cohort: dalbavancin as consolidation therapy in patients with endocarditis and/or bloodstream infection produced by gram-positive cocci
by: Carmen Hidalgo-Tenorio, et al.
Published: (2019-10-01)

Synergistic Meropenem/Vaborbactam Plus Fosfomycin Treatment of KPC Producing <i>K. pneumoniae</i> Septic Thrombosis Unresponsive to Ceftazidime/Avibactam: From the Bench to the Bedside
by: Alessandra Oliva, et al.
Published: (2021-06-01)

Oritavancin as sequential therapy for Gram-positive bloodstream infections
by: Williams Monier Texidor, et al.
Published: (2024-01-01)

Replication Dynamics for Six Gram-Negative Bacterial Species during Bloodstream Infection
by: Mark T. Anderson, et al.
Published: (2021-08-01)

Rapid Detection of Specific Gram-negative Microorganisms Causing Bloodstream Infections in Children with the Microarray Method
by: Gülhadiye Avcu, et al.
Published: (2020-06-01)

Bloodstream infections in pediatric patients with acute leukemia: Emphasis on gram-negative bacteria infections
by: Fu-Chun Kuo, et al.
Published: (2017-08-01)

Dalbavancin Sequential Therapy for Gram-Positive Bloodstream Infection: A Multicenter Observational Study
by: Nicholas Rebold, et al.
Published: (2024-03-01)

Impact of Location of Acquisition of Gram-Positive Bloodstream Infections on Clinical Outcomes Among Patients Admitted to Community Hospitals
by: Messina JA, et al.
Published: (2020-08-01)

Antimicrobial Resistance and Associated Risk Factors of Gram-Negative Bacterial Bloodstream Infections in Tikur Anbessa Specialized Hospital, Addis Ababa
by: Beshah D, et al.
Published: (2022-08-01)

Clinical Characteristics And Risk Factors In Mixed-Enterococcal Bloodstream Infections
by: Zheng C, et al.
Published: (2019-10-01)

Effect of appropriate empirical antimicrobial therapy on mortality of patients with Gram-negative bloodstream infections: a retrospective cohort study
by: Shanshan Xu, et al.
Published: (2023-05-01)

Extensively drug-resistant Gram-negative bacterial bloodstream infection in hematological disease
by: Zhou L, et al.
Published: (2019-02-01)

A Real-World Study Comparing Various Antimicrobial Regimens for Bloodstream Infections Caused by Carbapenem-Resistant Gram-Negative Bacilli in a Tertiary Hospital, Shanghai, China, from 2010 to 2017
by: Tan J, et al.
Published: (2020-07-01)

Management of enterococcal central line-associated bloodstream infections in patients with cancer
by: Hesham Awadh, et al.
Published: (2021-07-01)

Persistent bacteremia predicts poor outcomes among neutropenic patients with carbapenem-resistant gram-negative bloodstream infections receiving appropriate therapy
by: Abi Manesh Sathya Kumar, et al.
Published: (2023-02-01)

Bloodstream gram-negative bacterial infections in adult patients with leukemia: A retrospective review of medical records in a tertiary care hospital in Western Saudi Arabia
by: Reyan Merdad, et al.
Published: (2023-10-01)

Gram-negative ESKAPE bacteria bloodstream infections in patients during the COVID-19 pandemic
by: María Dolores Alcántar-Curiel, et al.
Published: (2023-03-01)

Genetic Basis of Antimicrobial Resistant Gram-Negative Bacteria Isolated From Bloodstream in Brazil
by: Melise Chaves Silveira, et al.
Published: (2021-03-01)

Shift in risk factors for mortality by period of the bloodstream infection timeline
by: Min Hyuk Choi, et al.
Published: (2024-02-01)

Increasing Gram-Negative Catheter-Related Bloodstream Infection in Cancer Patients
by: Julia Laporte-Amargos, et al.
Published: (2023-02-01)

The Impact of the COVID-19 Pandemic on the Antibiotic Resistance of Gram-Negative Pathogens Causing Bloodstream Infections in an Intensive Care Unit
by: Andreea Loredana Golli, et al.
Published: (2025-02-01)

Comparison of bloodstream and non-bloodstream infections caused by carbapenem-resistant Klebsiella pneumoniae in the intensive care unit: a 9-year respective study
by: Xiangyuan Sun, et al.
Published: (2023-09-01)

Epidemiology of Bloodstream Infections at a Cancer Center
by: Eduardo Velasco, et al.
Published: (2000-09-01)

Morganella morganii, an Emerging Cause of Bloodstream Infections
by: Kevin B. Laupland, et al.
Published: (2022-06-01)

Prevalence of Candida bloodstream isolates from patients in two hospitals in Vietnam
by: Nguyen Duy Bac, et al.
Published: (2019-05-01)

Clinical and molecular characteristics of KPC-producing Klebsiella pneumoniae bloodstream infections: Results of a multicentre study
by: Lucia Brescini, et al.
Published: (2025-03-01)

Prognostic Risk Factors of Carbapenem-Resistant Gram-Negative Bacteria Bloodstream Infection in Immunosuppressed Patients: A 7-Year Retrospective Cohort Study
by: Gao Y, et al.
Published: (2022-11-01)

Long term sepsis readmission, mortality and cause of death following Gram negative bloodstream infection: a propensity matched observational linkage study
by: John F. McNamara, et al.
Published: (2022-01-01)

An Update on Recent Clinical Trial Data in Bloodstream Infection
by: Adam G. Stewart, et al.
Published: (2024-11-01)

Polymicrobial methicillin-resistant Staphylococcus aureus bloodstream infections
by: Angelica Escalona, et al.
Published: (2024-11-01)

The importance of blood cultures in the effective management of bloodstream infections
by: Olga Burduniuc, et al.
Published: (2019-09-01)

Prevention of catheter-related bloodstream infections in patients on hemodialysis: challenges and management strategies
by: Soi V, et al.
Published: (2016-04-01)

Non-fermentative gram-negative bloodstream infection in northern Italy: a multicenter cohort study
by: Renato Pascale, et al.
Published: (2021-08-01)

Risk Factors of Bloodstream Infections Caused by Carbapenem-resistant Gram-negative Pathogens in Pediatric Critical Care Settings
by: Zümrüt Şahbudak Bal, et al.
Published: (2019-09-01)

The effect of follow-up blood cultures on mortality and antibiotic use in gram-negative bloodstream infections
by: Mehmet Yildiz, et al.
Published: (2023-08-01)